Changes for page Neurodiagnoses
Last modified by manuelmenendez on 2025/03/03 22:46
From version 43.1
edited by manuelmenendez
on 2025/02/05 11:14
on 2025/02/05 11:14
Change comment:
There is no comment for this version
To version 32.1
edited by manuelmenendez
on 2025/01/29 19:12
on 2025/01/29 19:12
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -2,9 +2,9 @@ 2 2 ((( 3 3 (% class="container" %) 4 4 ((( 5 -= //A new tridimensional diagnostic framework for complexCNS diseases// =5 += //A new tridimensional diagnostic framework for CNS diseases// = 6 6 7 -This project is focused on developing a novel nosological and diagnostic framework for complexCNS diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies.7 +This project is focused on developing a novel nosological and diagnostic framework for CNS diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies. 8 8 We aim to create a structured, interpretable, and scalable diagnostic tool. 9 9 ))) 10 10 ))) ... ... @@ -17,47 +17,22 @@ 17 17 18 18 = **Overview** = 19 19 20 +The classification and diagnosis of central nervous system (CNS) diseases have long been constrained by traditional phenotypic approaches that fail to capture the underlying pathophysiological mechanisms, molecular biomarkers, and neuroanatomical changes that drive disease progression. For instance, neurodegenerative and psychiatric disorders exhibit significant clinical overlap, co-pathology, and heterogeneity, a new diagnostic framework is urgently needed—one that shifts from symptom-based classifications toward an etiology-driven, tridimensional system integrating genetics, proteomics, neuroimaging, and computational modeling. By leveraging AI, multi-modal biomarkers, and precision medicine, this framework aims to provide a more objective, scalable, and biologically grounded approach to diagnosing and managing CNS diseases, ultimately leading to earlier detection, personalized interventions, and improved patient outcomes. 20 20 21 -The c lassificationand diagnosisof central nervoussystem (CNS)diseases havengbeenconstrainedby traditional,phenotype-basedapproachesthatoftenfail tocapturethecomplexinterplayof pathophysiological mechanisms, molecular biomarkers, and neuroanatomicalchanges. Neurodiagnoses redefines this landscape by integrating advanced AI with multi-modaldata—including genetics, neuroimaging, biomarkers, and digital health records—tocreate a moreprecise,scalable,anddata-drivendiagnosticystem.22 +The project aims to develop a tridimensional diagnostic framework with an AI-powered annotation system, integrating etiology, molecular biomarkers, and neuroanatomoclinical correlations for precise and scalable CNS disease diagnostics. 22 22 23 - Inaddition to these clinicaldiagnosticapproaches,Neurodiagnoses has expandedinto a research-orientedplatform through the integration of **CNSDigital Twins**. This cutting-edge conceptinvolvescreating a personalized digital replica of a patient’sCNS by incorporatingmulti-omics data (proteomics,genomics,lipidomics, transcriptomics), various neuroimaging modalities,and digital health information. Theseigitaltwins enablesimulations ofdisease progression,support the discovery ofnovel biomarkers, and help identify new therapeutic targets.24 +The //Tridimensional Diagnostic Framework// redefines CNS diseases can be classified and diagnosed by focusing on: 24 24 25 -On this page, you will find: 26 +* **Axis 1**: Etiology (genetic or other causes of diseases). 27 +* **Axis 2**: Molecular Markers (biomarkers). 28 +* **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system). 26 26 27 -* Detailed descriptions of both the clinical diagnostic tools and the research framework. 28 -* Access to our AI models, data processing pipelines, and digital twin simulations. 29 -* Collaborative resources for researchers, clinicians, and AI developers. 30 -* Guidelines and instructions on how to contribute to and expand the project. 30 +This methodology enables: 31 31 32 +* Greater precision in diagnosis. 33 +* Integration of incomplete datasets using AI-driven probabilistic modeling. 34 +* Stratification of patients for personalized treatment. 32 32 33 -== **The role of AI-powered annotation** == 34 - 35 -To enhance standardization, interpretability, and clinical application, the framework integrates an AI-powered annotation system, which: 36 - 37 -* Assign structured metadata tags to diagnostic features. 38 -* Provides real-time contextual explanations for AI-based classifications. 39 -* Tracks longitudinal disease progression using timestamped AI annotations. 40 -* Improves AI model transparency through interpretability tools (e.g., SHAP analysis). 41 -* Facilitates decision-making for clinicians by linking annotations to standardized biomedical ontologies (SNOMED, HPO). 42 - 43 -Neurodiagnoses provides two complementary AI-driven diagnostic approaches: 44 - 45 -1. Traditional Probabilistic Diagnosis 46 - 47 -* AI provides multiple possible diagnoses, each assigned a probability percentage based on biomarker, imaging, and clinical data. 48 -* Useful for differential diagnosis and treatment decision-making. 49 - 50 -2. Tridimensional Diagnosis 51 - 52 -* Diagnoses are structured based on: 53 -(1) Etiology (genetic, autoimmune, metabolic, infectious) 54 -(2) Molecular Biomarkers (amyloid-beta, tau, inflammatory markers, EEG patterns) 55 -(3) Neuroanatomoclinical Correlations (brain atrophy, connectivity alterations) 56 -* This approach enables precise disease subtyping and biologically meaningful classification, particularly useful for tracking progression over time. 57 - 58 -Both systems will be offered for every patient case, allowing clinicians to compare AI-generated probabilistic diagnosis with a structured tridimensional classification. 59 - 60 - 61 61 == **The case of neurodegenerative diseases** == 62 62 63 63 There have been described these 3 diagnostic axes: ... ... @@ -70,8 +70,6 @@ 70 70 * //Description//: Focuses on genetic and sporadic causes, identifying risk factors and potential triggers. 71 71 * //Examples//: APOE ε4 as a genetic risk factor, or cardiovascular health affecting NDD progression. 72 72 * //Tests//: Genetic testing, lifestyle, and cardiovascular screening. 73 - 74 - 75 75 ))) 76 76 * ((( 77 77 **Axis 2: Molecular Markers** ... ... @@ -79,8 +79,6 @@ 79 79 * //Description//: Analyzes primary (amyloid-beta, tau) and secondary biomarkers (NFL, GFAP) for tracking disease progression. 80 80 * //Examples//: CSF amyloid-beta concentrations to confirm Alzheimer’s pathology. 81 81 * //Tests//: Blood/CSF biomarkers, PET imaging (Tau-PET, Amyloid-PET). 82 - 83 - 84 84 ))) 85 85 * ((( 86 86 **Axis 3: Neuroanatomoclinical** ... ... @@ -108,13 +108,10 @@ 108 108 * Develop interpretable AI models for diagnosis and progression tracking. 109 109 * Integrate data from Human Phenotype Ontology (HPO), Gene Ontology (GO), and other biomedical resources. 110 110 * Foster collaboration among neuroscientists, AI researchers, and clinicians. 111 -* Provide a dual diagnostic system: 112 -** Probabilistic Diagnosis – AI assigns multiple traditional possible diagnoses with probability percentages. 113 -** Tridimensional Diagnosis – AI structures diagnoses based on etiology, biomarkers, and neuroanatomical correlations. 114 114 115 115 == Who has access? == 116 116 117 -We welcome contributions from the global community. Join us as we transform CNS diagnostics and drive precision medicine forward through a collaborative, open-source approach.Let’s build the future of neurological diagnostics together!85 +We welcome contributions from the global community. Let’s build the future of neurological diagnostics together! 118 118 ))) 119 119 120 120 ... ... @@ -135,7 +135,6 @@ 135 135 * `/data`: Sample datasets for testing. 136 136 * `/outputs`: Generated models, visualizations, and reports. 137 137 * [[Methodology>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Methodology/]] 138 -* [[Notebooks>>Notebooks]] 139 139 * [[Results>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Results/]] 140 140 * [[to-do-list>>to-do-list]] 141 141 )))